Observational Study in Infants Who Are Prescribed Treatment With Keppra® (Levetiracetam) Oral Solution

Mise à jour : Il y a 5 ans
Référence : NCT01210690

Femme et Homme

Extrait

The purpose of this observational study is to broaden the knowledge of the known safety and efficacy profile of Keppra® (Levetiracetam) oral solution in epileptic infants younger than 12 months when treated according to routine clinical practice. Their data will be collected until they reach the age of 13 months.


Critère d'inclusion

  • Epilepsy


Liens